Ben Nun Alon, Altman Eduard, Best Lael Anson
Ann Thorac Surg. 2005 Oct;80(4):1276-9. doi: 10.1016/j.athoracsur.2005.02.007.
In recent years, percutaneous tracheostomy has become a routine practice in many hospitals. In the early publications, most authors considered adverse conditions such as short, fat neck or obesity as relative contraindications whereas cervical injury, coagulopathy, and emergency were regarded as absolute contraindications. More recently, several reports demonstrated the feasibility of percutaneous tracheostomy in patients with some of these contraindications. The aim of this study is to determine the safety and efficacy of percutaneous tracheostomy in conditions commonly referred to as contraindications.
Between June 2000 and July 2001, 157 consecutive percutaneous tracheostomy procedures were performed on 154 critically ill adult patients in the general intensive care unit of a major tertiary care facility. The Griggs technique and Portex set were used at the bedside. All procedures were performed by staff thoracic surgeons and anesthesiologists experienced with the technique. Anatomical conditions, presence of coagulopathy and anti-coagulation therapy, demographics, and complication rates were recorded.
Five of 157 procedures (154 patients owing to three repeat tracheostomies) had complications. In patients with normal anatomical conditions and coagulation profiles, there was one case of bleeding (50 cc to 120 cc) and one case of mild cellulitis around the stoma. In patients with adverse conditions, there was one case of bleeding (50 cc to 120 cc) and two cases of minor bleeding (< 50 cc).
Patients with adverse conditions had a low complication rate similar to patients with normal conditions. For this reason, we believe that percutaneous tracheostomy is indicated in patients with short, fat neck; inability to perform neck extension; enlarged isthmus of thyroid; previous tracheostomy; or coagulopathy and anti-coagulation therapy.
近年来,经皮气管切开术在许多医院已成为常规操作。在早期的文献中,大多数作者将短粗颈或肥胖等不利情况视为相对禁忌证,而颈椎损伤、凝血功能障碍和急诊情况则被视为绝对禁忌证。最近,一些报告表明在部分存在这些禁忌证的患者中行经皮气管切开术是可行的。本研究的目的是确定在通常被称为禁忌证的情况下经皮气管切开术的安全性和有效性。
2000年6月至2001年7月期间,在一家大型三级医疗设施的综合重症监护病房对154例重症成年患者连续进行了157例经皮气管切开术。采用Griggs技术和Portex套件在床边进行操作。所有手术均由熟悉该技术的胸外科医生和麻醉医生进行。记录解剖情况、凝血功能障碍和抗凝治疗情况、人口统计学资料及并发症发生率。
157例手术中有5例(因3例重复气管切开术涉及154例患者)出现并发症。在解剖情况和凝血指标正常的患者中,有1例出血(50毫升至120毫升)和1例造口周围轻度蜂窝织炎。在存在不利情况的患者中,有1例出血(50毫升至120毫升)和2例少量出血(<50毫升)。
存在不利情况的患者并发症发生率与情况正常的患者相似且较低。因此,我们认为对于短粗颈、无法进行颈部伸展、甲状腺峡部增宽、既往有气管切开术或存在凝血功能障碍及接受抗凝治疗的患者,行经皮气管切开术是可行的。